Controlled release sulfonylurea formulation

Details for Australian Patent Application No. 2002306758 (hide)

Owner ANDRX CORPORATION

Inventors Chen, Chih Ming; Chou, Joseph; Wong, David

Agent Wrays

Pub. Number AU-A-2002306758

PCT Number PCT/US02/08306

PCT Pub. Number WO2002/074285

Priority 60/276,447 16.03.01 US

Filing date 18 March 2002

Wipo publication date 3 October 2002

International Classifications

A61K 009/24 Medicinal preparations characterised by special physical form - Layered or laminated unitary dosage forms

A61K 009/32 Medicinal preparations characterised by special physical form

A61K 009/36 Medicinal preparations characterised by special physical form

Event Publications

19 December 2002 Complete Application Filed

  Priority application(s): 60/276,447 16.03.01 US

27 March 2003 Application Open to Public Inspection

  Published as AU-A-2002306758

2 December 2004 Assignment before Grant

  Andrx Corporation The application has been assigned to Andrx Pharmaceuticals, LLC

7 April 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002306759-Recombinant P. vivax merozoite protein-1 p42 vaccine

2002306757-Methods and apparatus for decontaminating fluids